0001567619-21-021615.txt : 20211203
0001567619-21-021615.hdr.sgml : 20211203
20211203175324
ACCESSION NUMBER: 0001567619-21-021615
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211201
FILED AS OF DATE: 20211203
DATE AS OF CHANGE: 20211203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hindson Benjamin J.
CENTRAL INDEX KEY: 0001786391
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39035
FILM NUMBER: 211471362
MAIL ADDRESS:
STREET 1: 10X GENOMICS, INC.
STREET 2: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 10x Genomics, Inc.
CENTRAL INDEX KEY: 0001770787
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 455614458
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: (925) 401-7300
MAIL ADDRESS:
STREET 1: 6230 STONERIDGE MALL ROAD
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: 10X Genomics, Inc.
DATE OF NAME CHANGE: 20190315
4
1
doc1.xml
FORM 4
X0306
4
2021-12-01
0
0001770787
10x Genomics, Inc.
TXG
0001786391
Hindson Benjamin J.
C/O 10X GENOMICS, INC.
6230 STONERIDGE MALL ROAD
PLEASANTON
CA
94588
1
1
0
0
See Remarks
Class A Common Stock
2021-12-01
4
M
0
3646
5.04
A
50412
D
Class A Common Stock
2021-12-01
4
M
0
35232
11.48
A
85644
D
Class A Common Stock
2021-12-01
4
M
0
2788
74.58
A
88432
D
Class A Common Stock
2021-12-01
4
S
0
5400
145.6557
D
83032
D
Class A Common Stock
2021-12-01
4
S
0
5369
146.5263
D
77663
D
Class A Common Stock
2021-12-01
4
S
0
13561
147.6517
D
64102
D
Class A Common Stock
2021-12-01
4
S
0
7571
148.4211
D
56531
D
Class A Common Stock
2021-12-01
4
S
0
4849
149.4573
D
51682
D
Class A Common Stock
2021-12-01
4
S
0
1816
150.6621
D
49866
D
Class A Common Stock
2021-12-01
4
S
0
2100
151.4574
D
47766
D
Class A Common Stock
2021-12-01
4
S
0
100
152.2500
D
47666
D
Class A Common Stock
2021-12-01
4
S
0
700
153.9136
D
46966
D
Class A Common Stock
2021-12-01
4
S
0
200
155.55
D
46766
D
Stock Option (right to buy)
5.04
2021-12-01
4
M
0
3646
0.00
D
2028-11-02
Class A Common Stock
3646
47238
D
Stock Option (right to buy)
11.48
2021-12-01
4
M
0
35232
0.00
D
2029-05-10
Class A Common Stock
35232
33334
D
Stock Option (right to buy)
74.58
2021-12-01
4
M
0
2788
0.00
D
2030-04-21
Class A Common Stock
2788
133212
D
The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
This transaction was executed in multiple trades at prices ranging from $145.05 to $145.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $146.095 to $146.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $147.03 to $147.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $148.03 to $148.995. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $149.065 to $149.995. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $150.12 to $151.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $151.14 to $152.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $153.665 to $154.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This option, originally for 175,000 shares, of which 127,762 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
This option, originally for 100,000 shares, of which 66,666 shares have been exercised, vested as to 1/48th of the shares on May 1, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
This option, originally for 136,000 shares, of which 2,788 shares have been exercised, vested as to 1/48th of the shares on May 1, 2020 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Chief Scientific Officer and President
/s/ Eric S. Whitaker, as Attorney-in-Fact
2021-12-03